Compare Agilent Technologies Inc (A) vs AngloGold Ashanti Limited (AU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs AngloGold Ashanti Limited — how do they compare? Agilent Technologies Inc trades at $128.87 (market cap $37.04B), while AngloGold Ashanti Limited trades at $79.25 (market cap $41.50B). The key difference: Agilent Technologies Inc and AngloGold Ashanti Limited are close in size by market cap, and AngloGold Ashanti Limited pays the higher dividend (5.6%). Which is the better fit depends on your goals.
| A | AU | |
|---|---|---|
Market Cap | $37.04B | $41.50B |
Sector | Health | Basic Materials |
52-Week High | $157.20 | $128.26 |
52-Week Low | $110.24 | $45.22 |
Enterprise Value | $38.59B | $40.63B |
Dividend Yield | 0.78% | 5.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
AngloGold Ashanti (AU) trades at $82.01, down 3.12% on the day, near key support at $81. The stock shows strong fundamentals with 2025 revenue surging to $9.89B and net income reaching $2.64B, driving a robust 31.11% net margin. Recent Q1 2026 earnings beat expectations at $2.52 EPS, while the company announced a $1.16 dividend and a share repurchase program. Technical indicators signal bearish momentum with RSI at 80.83 suggesting overbought conditions, but analyst consensus remains bullish with a $118 price target.
Outlook is positive due to explosive revenue growth, high profitability, and shareholder returns, but risks include gold price volatility and execution challenges. The stock offers value with a P/E of 12.34, though technical weakness may pressure near-term performance. Institutional sentiment is supportive with 64% buy ratings, but investors should monitor gold market dynamics and cost inflation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →
